Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration

AIM: The aim of this article is to evaluate the rate of patients developing sustained elevated intraocular pressure (IOP) after ranibizumab (Lucentis) intravitreal (IVT) injections. DESIGN: This is a retrospective study. PARTICIPANTS: Charts of 192 consecutive patients receiving Lucentis for age-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Gustavo MSM, Grigg, John, Chua, Brian, Lee, Anne, Lim, Ridia, Higgins, Ralph, Martins, Alessandra, Goldberg, Ivan, Clement, Colin I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263879/
https://www.ncbi.nlm.nih.gov/pubmed/28138211
http://dx.doi.org/10.5005/jp-journals-10008-1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263879/
https://www.ncbi.nlm.nih.gov/pubmed/28138211
http://dx.doi.org/10.5005/jp-journals-10008-1213

Ejemplares similares